Management and integrity of the project design. Realization of research activities. Conducting and reporting of the project results. Managing, monitoring, and ensuring of collaborative research.
Educational researcher, competent in microbiological theory and methods, collecting, handling, analyzing, evaluating, and reporting data relative to the type and scope of the research, performing molecular and bioinformatics pipelines independently, several existing international research collaborations.
Dr. Arandjelović is a Specialist in Medical Microbiology and Ph.D. in Molecular Medicine. She is a member of the National Reference Laboratory for tuberculosis, and co-author of the national „Guide for microbiological diagnosis of tuberculosis“ (3rd edition, Belgrade, 2015). Research activities of Dr. Arandjelović are focused on mycobacteria, primarily on the evolution of multidrug-resistant (MDR) M. tuberculosis strains. From 2010 to 2015, she was engaged in several projects funded by the Ministry of Health of the Republic of Serbia and supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. She is engaged in the project „Bacteria resistant to antibiotics in Serbia: phenotypic and genotypic characterization“ funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia from 2011. Dr. Arandjelovic is collaborator of the Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) from 2017. Within CRyPTIC project, funded by the Bill & Melinda Gates Foundation and Wellcome Trust/MRC Newton Fund, she is a contributor of the whole genome sequencing data on MDR M. tuberculosis strains isolated in Serbia for bioinformatic and machine learning analyses aimed at predicting susceptibility and resistance of M. tuberculosis to antituberculosis drugs.
Serbian Medical Society, Serbian Medical Chamber, Serbian Society for Microbiology, Federation of European Microbiological Societies (FEMS), National Reference Laboratory for tuberculosis
2019 – collaboration with Department of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw (Dr. Tomasz Jagielski); contribution of M. kansasii strains isolated in Serbia for genotyping in order to establish the global prevalence of the newly proposed Mycobacterium species (former M. kansasii subtypes) in the context of patient socio-demographic and clinical data.
2017 – collaboration with Nuffield Department of Medicine, University of Oxford, Oxford, England (Dr. Timothy Walker); contribution of the WGS data on MDR M. tuberculosis strains from Serbia for the CRyPTIC Consortium.
2015 one month stay in the Molecular and Experimental Mycobacteriology Group, Research Center Borstel, Borstel, Germany (Lab Head Prof. Stefan Niemann) for training and performance of bioinformatic analysis of WGS data on 115 MDR M. tuberculosis strains isolated in Serbia from 2008 to 2014.
2014 three months stay in the Molecular and Experimental Mycobacteriology Group, Research Center Borstel, Borstel, Germany (Lab Head Prof. Stefan Niemann) for training and performance of spoligotyping, MIRU-VNTR and whole genome sequencing for 115 MDR M. tuberculosis strains isolated in Serbia from 2008 to 2014.
FEMS (Federation of European Microbiology Societies) Research Grant 2013 for research and training on performance of spoligotyping, MIRU-VNTR and whole genome sequencing at the Molecular and Experimental Mycobacteriology Group, Research Center Borstel, Borstel, Germany (3 months).
2011 – 2018 Specialization in Medical microbiology; Faculty of Medicine, University of Belgrade; an average grade 5.0/5.0
2009 – 2015 Ph.D. studies; module Molecular medicine, Faculty of Medicine, University of Belgrade; title of Ph.D. thesis “Species, phylogenetic lineages and genetic basis of resistance in multidrug-resistant Mycobacterium tuberculosis complex strains isolated in Serbia”; an average grade 10.0/10.0
2000 – 2008 Integrated academic studies of Medicine; Faculty of Medicine, University of Belgrade; an average grade 9.29/10.0